These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11823443)

  • 21. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Preumont V; Hermans MP; Lebecque P; Buysschaert M
    Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.
    Kreda SM; Mall M; Mengos A; Rochelle L; Yankaskas J; Riordan JR; Boucher RC
    Mol Biol Cell; 2005 May; 16(5):2154-67. PubMed ID: 15716351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild cystic fibrosis in patients with the rare P5L CFTR mutation.
    Spicuzza L; Sciuto C; Di Dio L; Mattina T; Leonardi S; del Giudice MM; La Rosa M
    J Cyst Fibros; 2012 Jan; 11(1):30-3. PubMed ID: 21983161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.
    Rubenstein RC; Zeitlin PL
    Am J Respir Crit Care Med; 1998 Feb; 157(2):484-90. PubMed ID: 9476862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of a delta F508 cystic fibrosis mouse model.
    Colledge WH; Abella BS; Southern KW; Ratcliff R; Jiang C; Cheng SH; MacVinish LJ; Anderson JR; Cuthbert AW; Evans MJ
    Nat Genet; 1995 Aug; 10(4):445-52. PubMed ID: 7545494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
    Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
    Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.
    Fulmer SB; Schwiebert EM; Morales MM; Guggino WB; Cutting GR
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6832-6. PubMed ID: 7542778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repairing the basic defect in cystic fibrosis - one approach is not enough.
    Farinha CM; Matos P
    FEBS J; 2016 Jan; 283(2):246-64. PubMed ID: 26416076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients.
    Casals T; Pacheco P; Barreto C; Giménez J; Ramos MD; Pereira S; Pinheiro JA; Cobos N; Curvelo A; Vázquez C; Rocha H; Séculi JL; Pérez E; Dapena J; Carrilho E; Duarte A; Palacio AM; Nunes V; Lavinha J; Estivill X
    Hum Mutat; 1997; 10(5):387-92. PubMed ID: 9375855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
    Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
    Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
    Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
    Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
    Rubenstein RC
    Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.